Letters, Testimony & Filings Letter to Congress Calling for Amendments to S. 3799, the PREVENT Pandemics Act March 14, 2022
Testimony Before the FDA’s Neurological Devices Advisory Committee Meeting Regarding BrainGate LTD’s Ischemic Stroke System December 10, 2021
Forum Article Published in Drug and Therapeutics Bulletin: Mandatory Disclosure of All Pharmaceutical and Medical Device Companies’ Payments to Healthcare Providers: Learning From the USA December 7, 2021
Letter to President Biden Opposing the President and CEO of the Biotechnology Innovation Organization as a Candidate for FDA Commissioner October 12, 2021
Letter to the FDA Urging the Agency Not to Grant 510(k) Premarket Clearance for the TriGUARD 3 Cerebral Embolic Protection Device August 17, 2021
Letters, Testimony & Filings Presentation at the FDA’s Stakeholder Meeting on the Reauthorization of MDUFA June 9, 2021
Comments on the FDA’s Proposed Rule Regarding the “Intended Uses” of Marketed Drugs and Medical Devices October 23, 2020